Press Releases

All Releases

Summary Toggle ICU Medical, Inc. to Present at the 17th Annual Morgan Stanley Global Healthcare Conference

Sep 9, 2019

SAN CLEMENTE, Calif. , Sept. 09, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Morgan

PDF Version
Summary Toggle ICU Medical, Inc. Announces Second Quarter 2019 Results

Aug 7, 2019

Company Updates FY 2019 Guidance SAN CLEMENTE, Calif. , Aug. 07, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Second Quarter 2019 Earnings Conference Call

Jul 17, 2019

SAN CLEMENTE, Calif. , July 17, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2019 earnings release

PDF Version
Summary Toggle ICU Medical CFO Announces Intention to Retire from CFO Role After Close of FY19

Jul 8, 2019

SAN CLEMENTE, Calif. , July 08, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Scott E.

PDF Version
Summary Toggle ICU Medical, Inc. Announces First Quarter 2019 Results

May 9, 2019

SAN CLEMENTE, Calif. , May 09, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2019 .

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of First Quarter 2019 Earnings Conference Call

Apr 18, 2019

SAN CLEMENTE, Calif. , April 18, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2019 earnings release

PDF Version
Summary Toggle ICU Medical, Inc. to Present at the Raymond James 40th Annual Institutional Investors Conference

Mar 1, 2019

SAN CLEMENTE, Calif. , March 01, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond

PDF Version
Summary Toggle ICU Medical, Inc. Announces Fourth Quarter 2018 Results

Feb 28, 2019

SAN CLEMENTE, Calif. , Feb. 28, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended December 31,

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2018 Earnings Conference Call

Feb 7, 2019

SAN CLEMENTE, Calif. , Feb. 07, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2018

PDF Version
Summary Toggle ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference

Dec 27, 2018

SAN CLEMENTE, Calif. , Dec. 27, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the 37 th J.P.

PDF Version
Summary Toggle ICU Medical, Inc. Announces Third Quarter 2018 Results

Nov 8, 2018

Company Modifies FY 2018 Guidance and Provides Initial FY 2019 Adjusted EBITDA Guidance SAN CLEMENTE, Calif. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Third Quarter 2018 Earnings Conference Call

Oct 22, 2018

SAN CLEMENTE, Calif. , Oct. 22, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its third quarter 2018 earnings release and

PDF Version
Summary Toggle ICU Medical, Inc. to Present at the 2018 Morgan Stanley Global Healthcare Conference

Sep 10, 2018

SAN CLEMENTE, Calif. , Sept. 10, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the 2018

PDF Version
Summary Toggle ICU Medical, Inc. Announces Second Quarter 2018 Results

Aug 9, 2018

Company Updates FY 2018 Guidance SAN CLEMENTE, Calif. , Aug. 09, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced financial results for

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Second Quarter 2018 Earnings Conference Call

Jul 17, 2018

SAN CLEMENTE, Calif. , July 17, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its second quarter 2018 earnings release

PDF Version
Summary Toggle ICU Medical, Inc. Announces First Quarter 2018 Results

May 9, 2018

SAN CLEMENTE, Calif. , May 09, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial results for the quarter ended March 31, 2018 .

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of First Quarter 2018 Earnings Conference Call

Apr 12, 2018

SAN CLEMENTE, Calif. , April 12, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its first quarter 2018 earnings release

PDF Version
Summary Toggle ICU Medical, Inc. to Present at Raymond James’ 39th Annual Institutional Investors Conference

Mar 2, 2018

SAN CLEMENTE, Calif. , March 02, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond

PDF Version
Summary Toggle ICU Medical, Inc. Announces Fourth Quarter and Fiscal Year 2017 Results

Mar 1, 2018

Company Updates FY 2018 Adjusted EPS Guidance SAN CLEMENTE, Calif. , March 01, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced financial

PDF Version
Summary Toggle ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2017 Earnings Conference Call

Feb 5, 2018

SAN CLEMENTE, Calif. , Feb. 05, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today announced the time of its fourth quarter and fiscal year 2017

PDF Version

Infusion Therapy

Oncology

Critical Care

Specialty

Infusion Therapy

Oncology

Critical Care

Support

About Us

Investors

Stock Quote [NASDAQ: ICUI]

Shareholder Tools

Press Releases

All Releases